US health authorities will allow emergency use of Gilead's coronavirus treatment
The US Food and Drug Administration will allow emergency use of Gilead's coronavirus treatment remdesivir.
The move allows for broader use of remdesivir. However an emergency use authorization is not regulatory approval. The FDA can apply a lower standard of evidence to allow emergency use. The regulatory action quickly follows positive trial results showing the drug, called remdesivir, helped coronavirus patients recover 31% faster than a group that got a placebo.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Gilead CEO on remdesivir: manufacturing, pricing for coronavirus drug - Business InsiderGilead plans to spend up to $1 billion to ramp up manufacturing of its coronavirus treatment, but execs dodged Wall Street's questions about turning a profit
Leer más »
Elon Musk ripped US infrastructure, calling many American airports an 'embarrassment' - Business Insider'It's really quite sad that US infrastructure, especially roads and highways, is where it is today,' Elon Musk said.
Leer más »
Coronavirus: UK ambassador to US backs investigation into origin - Business InsiderDame Karen Pierce said on Wednesday there 'definitely needs to be some sort of review or investigation.'
Leer más »
Elon Musk says US shelter-in-place orders fascist, unAmerican in rant - Business Insider'GIVE PEOPLE BACK THEIR GODDAMN FREEDOM': Elon Musk bashes US shelter-in-place orders as fascist, says they're 'forcibly imprisoning' people in their homes
Leer más »
The US blacklisted five Amazon websites as 'notorious markets' - Business InsiderThe Trump administration blacklisted 5 overseas Amazon websites as 'notorious markets' and Amazon says it's political bullying
Leer más »
US weekly jobless claims hit 3.8 million as coronavirus layoffs continue - Business Insider'It's a very uncomfortably large share of the workforce,' Michelle Meyer, chief US economist at Bank of America told Business Insider.
Leer más »